EMA’s public hearing on Valproate

Yesterday (September 26th), Karen Keely of the FACS Forum Ireland addressed the EMA’s public hearing on valproate in London. The hearing was investigating whether 2014 European-wide measures to restrict the use of valproate in girls and women of childbearing potential have been effective and whether additional measures to reduce risks associated with the drug are needed.

A full transcript of Karen’s speech is below.